Log in
Enquire now
‌

US Patent 9518057 Derivatives and methods of treating hepatitis B infections

Patent 9518057 was granted and assigned to Novira Therapeutics on December, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Novira Therapeutics
Novira Therapeutics
0
Current Assignee
Novira Therapeutics
Novira Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
95180570
Patent Inventor Names
Scott Kuduk0
George D. Hartman0
Date of Patent
December 13, 2016
0
Patent Application Number
149843250
Date Filed
December 30, 2015
0
Patent Primary Examiner
‌
Heidi Reese
0
Patent abstract

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9518057 Derivatives and methods of treating hepatitis B infections

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.